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A B S T R A C T
Zinc tetrasulfonated phthalocyanine (ZnPcS4), was studied in aqueous solutions, films and at the
biological interfaces of noncancerous and cancerous human breast tissues by using steady state and
time resolved spectroscopy methods, including IR, Raman, UV vis, fluorescence and transient
absorption femtosecond pump probe spectroscopy. The pump probe transient absorption spectra were
recorded on time scales from femtoseconds to nanoseconds providing insight into the molecular
mechanisms of energy dissipation and primary events occurring in solution, film, and at the interface of
the biological tissues. The nature of the rapid processes and competing relaxation pathways resulting
from the initially excited electronic states of ZnPcS4 in aqueous solutions, films and at the biological
interfaces of cancerous and noncancerous human breast tissues was studied. The results provide
evidence that the sulfonated zinc phthalocyanine dissipates energy through different pathways in the
environment of the noncancerous tissue and of the cancerous tissue. A detailed understanding of the
paths of energy dissipation will reveal the mechanisms underlying light induced signal transduction and
the role of photoreceptors in photostability of living cells. Here, we showed that both the dynamics of the
ground state S0 recovery and the dynamics of the first excited state S1 decay at the interfacial regions of
the noncancerous tissue is markedly faster than that in the cancerous tissue, suggesting that the
molecular mechanisms responsible for harvesting the light energy in photosensitizers can be used for
practical applications in cancer diagnostics. The paper bridges the fundamentals of cancer research with
the femtosecond technologies of high temporal resolution for studying dynamics of photosensitizers in
noncancerous and cancerous human breast tissues.1. Introduction
Biological systems must effectively acclimate to maintain
photostability, because there would be no life on earth without
it. Thus, molecular biological structures responsible for harvesting
solar energy must be resistant to photo induced chemical changes.
This feature determines the health disease balance in living
creatures. When the photostability protection and reparation
mechanisms fail, the processes that convert noncancerous tissue
into abnormal tissue are strongly enhanced, leading to disease.* Corresponding author.
E-mail address: abramczy@mitr.p.lodz.pl (H. Abramczyk).Therefore, it is important to characterize the mechanisms
governing photostability in living biological systems [1].
To examine photostability new analytical tools, such as Raman
imaging and femtosecond spectroscopy, providing high temporal
or spatial resolution are required. The high temporal resolution is
needed to monitor the primary events occurring upon light
excitation, while the high spatial resolution is required to map the
localization and distribution of exogenous probes and endogenous
cellular components [2,3].
Raman imaging and femtosecond spectroscopy may open new
expanses in cancer biology particularly in metabolic and epigenetic
modifications of cancer, and bring revolution in cancer detection
and treatment. Limited number of papers has been reported on
ultrafast dynamics of biologically important molecules such as:
proteins and lipids [4 8]. Despite of several model studies that
Fig. 1. Anionic and cationic zinc photosensitizers.
 2have been done so far, no ex vivo ultrafast dynamics of human
tissue have been reported yet. High spatial [9 14] and temporal
resolution [15 20] allows to detecting a single cancerous cell in
vivo and monitor molecular events that occur inside and
contribute to cancer development.
In the present study, we used sulfonated zinc phthalocyanine as
an exogenous probe to examine the processes occurring at the
biological interfaces of human breast tissue. Phthalocyanines play
an important role as photosensitizers in conventional and targeted
photodynamic therapy (PDT) [15 82] and the mechanisms and
dynamics of energy transfer are crucial in this therapy. PDT is a
three component therapy involving the photosensitizer (phthalo
cyanine), the visible light absorbed through the photosensitizer
and molecular oxygen. The photosensitizer, accumulated or
retained in the target components of human cells, absorbs light
and induces a sequence of photophysical events, such as excited
singlet state fluorescence emission, intersystem crossing to a
triplet state or electron transfer. The energy dissipation depends on
many factors, such as phthalocyanine aggregation or photoinduced
reactions at photosensitized interfaces. Aggregation also depends
on many factors, such as a central metal, substituent type and
solvent composition. Dimers and higher ordered aggregates are
generally non fluorescent, as these structures have efficient
channels for non radiative relaxation. Thus, aggregation decreases
the efficiency of the radiative paths that return the photosensitizer
to the ground state via fluorescence or long lived phosphores
cence. In contrast, the excited monomeric species of the
photosensitizer once upon irradiation emits fluorescence [83].
In this study, we used pump probe femtosecond transient
absorption spectroscopy to examine the primary processes
occurring in sulfonated zinc phthalocyanine (ZnPcS4). However,
the early femtosecond and picosecond responses to light irradia
tion provide only limited information, as multiple cellular targets
make it difficult to distinguish the critical events of PDT that lead to
cell death. To understand the molecular basis of cancer cell death
through PDT, time resolved spectroscopy methods must be
combined with other sensitive techniques that are capable of
elucidating the driving forces preceding formation of ROS (reactive
oxygen species) from the excited photosensitizer. The sensitive
techniques, such Raman and fluorescence imaging, are useful for
photosensitizer localization and mapping cellular events during
and after photosensitization [2,3]. It has been shown that the
degree of photosensitizer aggregation affects localization and
distribution [84,85]. PDT initiates three types of programmed cell
death (PCD): apoptosis, necrosis or autophagy. The exact mecha
nism underlying the induction of PCD remains unknown, but it
seems that ROS generated from the excited photosensitizer are the
driving force underlying these events [86,87].
The detailed mechanisms of photosensitizer localization have
been previously discussed [20,85,87]. The initial subcellular
localization of each photosensitizer depends on many factors,
such as charge, hydrophobicity and plasma protein binding affinity.
Based on the charge and hydrophilic or lipophilic properties, the
photosensitizer can be localized in the various cytoplasmic
membranous structures of certain types of cells or compartments,
such as a membrane surfaces, endosomal compartments, organ
elles and cytoplasm. Briefly, the charge determines the anionic,
cationic, amphiphilic or neutral characteristics of photosensitizers
and plays an important role in the cellular uptake and photody
namic efficacy of PDT [79]. One of the most important types of
interactions between photosensitizers and membrane lipids are
electrostatic interactions. The higher efficiency of binding of water
soluble tetrasubstituted cationic aluminum phthalocyanine to
phospholipid membranes compared to the anionic tetrasulfonated
aluminum and zinc phthalocyanine complexes has been proven
[80]. This higher efficiency can be easily explained by electrostaticinteractions of the photosensitizer with negatively charged lipids
contained in the membrane [81]. The hydrophilic or lipophilic
properties of the photosensitizers are related to their structure,
which regulates aggregation and the efficiency of singlet oxygen
production [84]. Among the hydrophilic photosensitizers, anionic
derivatives with sulfo substituents (Fig.1), such as ZnPcS4 or AlPcS4
are one the best photosensitizers. It has been reported that the
high lipophilicity correlates with high cancer affinity of the
photosensitizer, while high hydrofility correlates with high
phototoxicity of the photosensitizer [82]. Moreover, it has been
shown that anionic phthalocyanines have higher selectivity in
binding process than cationic phthalocyanines and some cationic
compounds can be used in targeted therapy for destroying specific
subcellular organelles such as mitochondria [88 92]. Although the
cellular mechanisms of the mitochondrial pathway involved in
cancer cell elimination through photodynamic therapy remain
largely unclear, several studies on the mechanism of PDT induced
apoptosis have suggested the involvement of pro  and anti
apoptotic proteins, e.g., Bcl 2, Bax, Bcl XL, and most importantly
p53 [86,87,93]. The tumor suppressor protein p53 is critically
involved in defense against genome alterations resulting from DNA
damage. Although the precise role of p53 remains elusive, it has
recently been well documented that p53 confers a crucial barrier
for cancer progression, as p53 inactivation during tumorigenesis
occurs with high frequency via multiple mechanisms [86,87].
The significant progress made since the mid 1990s in cancer
detection and PDT therapy correlates with the development of
selective photosensitizers localized to specific sites of cells and
tissues such as plasma membrane, nuclei, mitochondria, and
lysosomes [94,95]. The high specificity of these new photo
sensitizers can be enhanced by using conjugated antibodies that
 3recognise and bind to cancer cells [96 98]. The targeting approach
combining nanoparticles with laser spectroscopy and Raman
imaging can potentially revolutionize cancer diagnosis and therapy
[11,95]. In the present study, we focused on the biological
interfaces after suspension and adsorption of photosensitizer in
a biological medium of noncancerous and cancerous human breast
tissues. Tetrasulfonated zinc phthalocyanine (Fig. 2) was selected
as a hydrophilic and anionic photosensitizer to identify the
primary processes occurring upon excitation of the chromophore.
We examined the vibrational properties and dynamics of
sulfonated zinc phthalocyanine at the biological interface of the
human breast tissues in a time window ranging from femto
seconds to nanoseconds. The results were compared with the
dynamics of the photosensitizer in the film on the glass support
and in aqueous solutions. Understanding mechanisms of energy
dissipation at the biological interface is a key challenge of
photochemistry of photosensitizers in vivo. Although photochem
ical properties of photosensitizers in liquid solutions has been well
documented [49 58]. We have shown [20] that bulk solution
properties of photosensitizers at biological interfaces cannot be
translated to the solid phase. Therefore, the photochemistry of
photosensitizers must be significantly revised when considering
biological interfaces. A limited number of papers have reported on
the dynamics of the primary events upon light excitation in thin
phthalocyanines films [12,15,60,65,73,75,80,99 105].
Although the primary PDT mechanism has been associated with
the selective accumulation of photosensitizers in cancer tissue, it
remains completely unclear whether the photochemical pathways
of energy dissipation upon light excitation are the same in the
noncancerous and cancerous tissues. The answer to this long
standing question, representing a key challenge in clinical
applications, can be elucidated using the time resolved pump
probe method to monitor pathways of photodynamic reactions in
regions of noncancerous and cancerous cells.Fig. 2. Hydrophilic and anioThe aim of the present study was to elucidate the processes
responsible for the ultrafast dynamics of ZnPcS4 at biological
interfaces of the human noncancerous and cancerous tissues
occurring on a time scale from femtoseconds to nanoseconds by
using the pump probe transient absorption spectroscopy. The
ultrafast dynamics was induced through femtosecond laser pulses
centered at 674 and 633 nm corresponding to the absorption
maxima of the Q band of the monomer and dimer, respectively.
2. Experimental section
2.1. Phthalocyanine
Zinc phthalocyanine tetrasulfonic acid, tetrasodium salt
(ZnPcS4) was prepared using a method similar to that of Griffiths
et al. [106]. More details about the synthesis can be found
elsewhere [20]. Scheme 1 illustrates the method used for the
synthesis of ZnPcS4.
This method generated a single regioisomer, presented in Fig. 3.
Fig. 3 shows the structure of the metal phthalocyanine, zinc (II)
phthalocyanine 3,40,40 0,40 0 0 tetrasulfonic anion.
2.2. Steady state UV vis absorption measurements
UV vis absorption electronic spectra were recorded with a
Varian Cary 5E spectrophotometer using 2 and 0.10  0.005 mm
detachable quartz cells (Hellma). The spectra were recorded at
293 K for the aqueous solutions at concentration of c = 10 3M, as
well as ZnPcS4 films on BaF2 supports and the thin sections of
16 mm of cancerous and noncancerous human breast tissue
samples stained with ZnPcS4.nic character of ZnPcS4.
Scheme 1. Method used for the synthesis of ZnPcS4 via the condensation of the sulfonated precursors in the presence of urea, the selected metal salt and a catalyst.
Fig. 3. Structure of the metal phthalocyanine, zinc(II)phthalocyanine-3,40 ,40 0 ,40 0 0-
tetrasulfonic anion.
 42.3. Pump probe transient absorption spectroscopy
The source of femtosecond pulses was a mode locked titanium
sapphire femtosecond laser (MIRA, Coherent, 800 nm, 76 MHz, 9 nJ,
<200 fs) pumped with iode pumped solid state laser (VERDI V5,
Coherent, 532 nm). The fundamental beam was amplified with Ti:
Sapphire regenerative amplifier (Coherent Legend USP, 800 nm,
1 kHz, 3 mJ, 50 fs). The regenerative amplifier was pumped withFig. 4. Histological images of the cancerous (infiltrating ductal carcinoma G2, from the tu
patient P95.diode pumped Nd:YLF laser (JADE, Thales Laser, 527 nm, 1 kHz,
20 mJ, <200 ns). The pulse was split in two and further amplified to
a dual single pass amplifier (Coherent Elite Duo, 800 nm, 1 kHz,
2  4.5 mJ, 50 fs). This amplifier was pumped through high power
Nd:YLF laser (Evolution, Coherent, 527 nm, 50 mJ, <200 ns). The
output of the laser system was split and two 1 mJ laser pulses were
used to pump two optical parametric amplifiers (OPA, model
TOPAS from Light Conversion). These OPA, combined through
frequency conversion modules, generated femtosecond pulses
tunable in the 300 and 2600 nm ranges. More details about the
femtosecond laser setup can be found in Ref. [20].
2.4. Patients and samples
We examined human ductal and lobular carcinoma (in situ and
infiltrating) and various benign changes, including benign
dysplastic and neoplastic lesions [107,108]. Raman spectroscopy
and Raman imaging have been previously used to analyze breast
cancer specimens [109 111]. The breast tissue samples were
obtained during a surgical operation. The research did not affect
the course of the operation or treatment of the patients. All
procedures were conducted using the protocol approved through
the institutional Bioethical Committee at the Medical University of
Lodz, Poland (RNN/30/11/KE). The detailed description of the
sample preparation procedure can be found in Ref. [20].
2.5. Infrared spectroscopy
IR spectra were recorded using a Specord M 80, Germany.
Specord M80 is a double beam spectrometer for the measurement
of lead 4000 200 cm 1 (2.5 50 mm) with an accuracy ranging
from +/  0.8 cm 1 to +/  0.3 cm 1, depending on the spectralmor mass) (a) and noncancerous (from the safety margin) (b) human breast tissue of
 5range. The spectra were scanned with a 4 cm 1 step and recorded
in a 800 4000 cm 1 range at 293 K.
3. Results and discussion
To learn about the properties of the photosensitizers at the
interface of cancerous and noncancerous tissues and the corre
sponding biochemical components of the tissue that form
biological environment for the photosensitizers we employed a
broad range of spectroscopic methods.
In this section, the results for the photosensitizer (ZnPcS4) at
the interface of the noncancerous and cancerous human breast
tissues using various methods, such as Raman, IR, and UV vis
steady state spectroscopy methods and time resolved transientFig. 5. Raman spectra of the noncancerous (a) and cancerous (infiltrating ductal carcin
window.electronic absorption through the pump probe femtosecond
spectroscopy will be presented.
Fig. 4 presents the histological images of the tumor mass
(cancerous tissue) and tissue from the safety margin (noncancer
ous tissue) of the same patient P95. The samples obtained from this
patient have also been used to record the Raman and IR spectra to
analyze the biochemical composition of cancerous and noncan
cerous human breast samples.
The histological images were obtained by staining with
hematoxylin and eosin (H&E). H&E staining facilitates the
assignment of various structures in tissues and single cells
[107]. Hematoxylin stains all basophilic components blue,
particularly the nucleus, containing DNA and RNA, and the rough
endoplasmic reticulum as a result of the coordinated bondingoma G2) (b) breast tissues from patient P95, using a 16-mm layer of tissue on BaF2
 6between aluminum and the phosphor atoms in DNA and RNA
[112]. Eosin stains cytoplasm, connective tissue and collagen fibers
(eosinophilic substances) red due to the ionic bonds between the
anionic dye and cationic plasma proteins.
To understand the details of the histological images presented
in Fig. 4, we will discuss the basic information on the morphology
of the human breast. The human breast consists of 6 10 major duct
systems. Each system contains numerous lobules, which terminate
ducts. Adipose tissue and supporting stroma surrounds these ducts
and lobules. The disease develops in the epithelial cells of the ducts
(ductal carcinoma) and lobules (lobular carcinoma). These tissues
contain no blood vessels; thus, nourishment is provided via the
diffusion of substances from the connective tissue surrounding the
epithelial structures [113]. These structures can be easily seen in
the histological H&E images presented in Fig. 4. The epithelial cells
are surrounded by the stroma, which predominantly, but not
exclusively, comprises connective tissue (type I collagen) (Fig. 4a)
and adipose tissue (Fig. 4b). The surface of the cancerous tissue is
hydrophilic [114], and the level of various proteins is markedly
elevated during disease development. In contrast, the noncancer
ous breast tissue consists of fatty tissue and is hydrophobic, as this
tissue primarily comprises glycerol monooleate [114].
3.1. Steady state Raman scattering
To obtain insight into the vibrational properties of the tissue
constituents at biological interfaces at the molecular level and
characterize the nature of these interactions, we analyzed the
Raman vibrational features in the noncancerous and the cancerous
tissues. Fig. 5 shows the typical Raman spectra of the noncancerous
and cancerous human breast tissues of patient P95, with the
tentative assignments of major vibrational bands.
The results show that the Raman spectra contain multiple
contributions from proteins, lipids, and nucleic acids, with
contributions from individual RNA and DNA bases (adenine,
thymine, guanine, cytosine, and uracil) and the sugar phosphate
backbone of DNA. A detailed inspection of Fig. 5a and b revealed
that the Raman spectra are characteristic of adipose rich regions,Table 1
Characteristic Raman peaks for noncancerous and cancerous breast tissues of adipose-
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Abbreviations: (bend.) bending, (wag.) wagging, (def.) deformation, (tw.) twist, (sym.) sphospholipid rich regions (Table 1), disordered collagen regions
(Table 2), collagen poor regions (Table 3).
The results shown in Fig. 5 highlight differences between the
Raman spectra of the noncancerous breast tissue from the safety
margin (Fig. 5a) and the cancerous breast tissue from the tumor
mass (Fig. 5b). Comparing the spectra in Fig. 5a and b one can
notice that the noncancerous human breast tissue contains Raman
peaks at 2854, 2888, and 2926 cm 1 typical for glycerol mono
oleate derivatives [12 14,120,121]. These peaks are not observed in
the Raman spectrum of the cancerous tissue for which a protein
peak at 2938 cm 1 is characteristic. One can also see from Fig. 5
that the strong signals at 1158 cm 1 and 1518 cm 1 in the Raman
spectrum of the noncancerous tissue are clearly visible. These
peaks originate from carotenoids, which are not observed in the
cancerous human breast tissue. It indicates that the noncancerous
human breast tissue contains a higher amount of glycerol
monooleate derivatives typical for adipose tissue, which act as
reservoir of carotenoids and fatty acids. The third most important
difference between the noncancerous and cancerous human breast
tissues is observed in the Raman spectra of the Amide I. The
maximum peak position of Amide I has been shifted from
1660 cm 1 in the cancerous tissue to 1654 cm 1 in noncancerous
tissue. This effect must be associated with the distinct biological
environment, potentially related to the disordered and alpha
helical protein structures, respectively. Many distinctions can also
be observed in the region of 2800 3000 cm 1 typical for lipid/
protein vibrations, where the contribution from the monounsatu
rated fatty acids, common constituents of triglycerides of the
adipose tissue, dominates the Raman spectrum of the noncancer
ous tissue in contrast to the Raman spectra of the cancerous tissue.
We have shown that the Raman spectra of the cancerous tissue
demonstrate a protein like profile [12 14,118,121 123]. This
finding is consistent with the knowledge that in contrast to
noncancerous cells, abnormal cells divide in an uncontrolled
process of cell growth and synthesize large amounts of proteins.
Tables 1 3 show the strongest Raman signals for the
noncancerous and the cancerous tissues and the tentative
assignments.rich regions, phospholipid-rich regions.
tative assignments
cleic Acids, Phospholipid (choline) [112–114]
otenoids/Phenylalanine [115]
C) str.
ids/Collagen [112,113]
C) str.
otenoids (C-C str.)/Proteins (C-C/C-N str.) [112–116]
cleic Acids (T, A)/Proteins (Amide III), Lipid, phospholipid CH bend [112,113]
ids, phospholipids [112]
H2) tw
ids/Proteins [115,117]
H) wag.
otenoids [116]
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teins Amide I/Unsaturated fatty acids [112,117]
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ids [112,117]
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ymmetric, (antisym.) antisymmetric, and (str.) stretch.
Table 3
Characteristic Raman peaks for noncancerous and cancerous breast tissues of
collagen-poor regions.
Wavenumber/cm 1 Tentative assignments
838 Nucleic acids, Proteins [113]
(O-P-O) antisym. str./ring br. Tyrosine
1076 Proteins/Lipids [117]
(C-N) str./chain (C-C) str.
1127 Proteins/Lipids/Carbohydrates [117]
(C-N) str./chain (C-C) str./(C-O) str.
1304 Lipids, phospholipids [112]
(C-H2) tw.
1444 Lipids/Proteins [115,117]
(C-H) wag.
1655–1680 Proteins Amide I/Unsaturated fatty acids [112,117]
a helix, (C-N) str., (C-H) def./C C str.
Abbreviations: (wag.) wagging, (tw.) twist, (sym.) symmetric, (antisym.) antisym-
metric, and (str.) stretch.
Fig. 6. Comparison between the IR spectra of the cancerous (infiltrating ductal
carcinoma G2) and noncancerous breast tissues of patient P95 at 0% humidity.
Table 2
Characteristic Raman peaks for noncancerous and cancerous breast tissues of disordered collagen regions.
Wavenumber/cm 1 Tentative assignments
814 Collagen/RNA [112,117]
(C-C)/(O-P-O) str.
852 Collagen, Tyrosine [121,113]
880 Lipids/Carbohydrates/Collagen [112]
(C-C-N+), (C-O-C) ring, (C-C)
935 Hydroxyproline/Collagen backbone [113,114]
(C-C)
1018 Collagen [113]
(C-N)
1031 Collagen [113]
(C-C)
1125 Carbohydrates (C-O)/Proteins (C-N str.) [112,113]
1220–1285 Nucleic Acids (T, A)/Proteins (Amide III)/Lipid, phospholipid ( CH bend.) [112,113]
1444 Lipids/Proteins [115,117]
(C-H) wag.
1655–1680 Proteins Amide I/Unsaturated fatty acids [112,117]
a helix, (C-N) str., (C-H) def./C C str.
3311 Water [113]
(OH) str.
3060 Nucleic acids/Proteins [117]
(C-H) aromatic
Abbreviations: (A) adenine, (T) thymine, (bend) bending, (wag.) wagging, (def.) deformation, (tw.) twist, (sym.) symmetric, (antisym.) antisymmetric, and (str.) stretch.
 73.2. Steady state IR absorption
To obtain complementary information concerning the vibra
tional properties of the noncancerous and cancerous tissues, it
would be interesting to compare the Raman spectra with IR
spectra. Fig. 6 shows the typical IR spectra for the cancerous breast
tissue of the same patient (P95) shown in Fig. 5. The results show
that the absorbance of various vibrations differs markedly,
particularly in the region of Amide I and fatty acids (1642, 1651,
1670, and 1686 cm 1).
Table 4 presents the tentative assignments of major vibrational
bands of IR spectra for the cancerous (infiltrating ductal carcinoma
G2) and the noncancerous breast tissues of patient P95.
A detailed analysis of the IR and Raman spectra of the human
breast tissue is beyond the scope of this paper, and additional
report directly related to this issue will be prepared in future
studies.
3.3. Steady state electronic absorption measurements
To obtain information concerning the electronic features of the
photosensitizer in the noncancerous and cancerous tissues we
have compared the electronic spectra of ZnPcS4 in various
environments.
Fig. 7a shows the steady state electronic absorption spectra of
ZnPcS4 in water, in the film on a glass support, and at the biological
interface of noncancerous and cancerous human breast tissues.
The results show that sulfonated zinc phthalocyanine absorbs in
the 600 680 nm region, known as the Q band, corresponding to a
p p* ring transition [124]. Another intensity band, due to
electronic transitions, consistent with the B (or Soret band), is
observed at 335 nm. A maximum at around 679 nm (Fig. 7a) has
been attributed to the Q band ((a2u) ! (eg) transition) of ZnPcS4
monomers in aqueous solution. Recently we have shown [5] that
the absorption band shape and the intensity change in the
concentration range of 10 6 10 2M, indicating that aggregation of
ZnPcS4 molecules in aqueous solution occurs. The band at 633 nm
in Fig. 7a has been assigned to a dimer or higher aggregates. As for
most metallophthalocyanines, the ZnPcS4 dimers with a cofacial
dimer geometry [125 127] show absorption that is blue shifted
relative to the monomer absorption band at 679 nm. The face to
face aggregation, reflecting the extensive interaction between the
Table 4
The tentative assignments of major vibrational bands of IR spectra for the cancerous (infiltrating ductal carcinoma G2) and noncancerous breast tissues of patient P95.
Wavenumber/cm 1 Tentative assignments
1096 Phospholipids, O-P-O sym. str. [113]
1160 Carotenoids CC str. [115]
1199 CC6H5 Phe, Trp [112]
1238 Phospholipid, O-P-O asym. str. [113]
1220–1285 Nucleic Acids (T, A)/Proteins (Amide III), Lipid, phospholipid ( CH bend.) [112,113]
1299 Lipids, phospholipids [112]
CH2 tw.
1383 Lipids CH3 sym. bend., lipids [113]
1402 Amine CN str. [113]
Lipids N + (CH3)3 sym. bend.
1461 Phospholipids (CH2) scissoring [113]
1551 Amide II, proteins [113]
1580 Nucleic acids [112,113]
1642 Water OH bend [113]
1655–1680 Proteins Amide I [112,117]
a helix, CN stretch, CH deformation, Unsaturated fatty acids
C C str. [112,117]
1738 Lipids C O str. [113,115,117,119]
1742 Lipids C O str. [113,115,117,119]
Abbreviations: (bend) bending, (wag) wagging, (def.) deformation, (tw) twist, (sym) symmetric, (antisym) antisymmetric, and (str) stretch.
 8p systems of adjacent rings [125], is stabilized through hydrogen
bonding in tetrasulfonated ZnPcS4 [127].
In contrast to the solutions, the absorption spectra at the
biological interface of the tissues and in the film presented in
Fig. 7a exhibit broad, structureless bands characteristic for the
absorption of monomers, dimers, and higher order aggregates.
Assuming the thickness of the ZnPcS4 layer for about 100 mm we
have estimated the concentration of the photosensitizer in the
tissues to be around 10 2M.
For comparison, in Fig. 7b we showed the steady state
absorption spectra of AlPcS4 in water solution, in a film, and at
the biological interface of noncancerous and cancerous human
breast tissues. AlPcS4 does not to aggregate in either aqueous or
organic solvents [128]. The sharp band at around 679 nm has been
assigned to monomeric species, and the weak band at 602 nm to
the vibronic band.
Excited state dynamics of ZnPcS4 at biological interfaces of the
human cancerous and noncancerous breast tissues, films and in
aqueous solutions. S0 ! S1 transition (Q band transition).
Upon absorbing a photon, a molecule is promoted to higher
energy states and very quickly relaxes back to ground state through
radiative or non radiative (heat) pathways. All these pathways can
be depicted in the Jablonski diagram [129].
When radiative path is chosen, profound chemical rearrange
ments occur leading to dangerous photoreactions in living cells,
thereby reducing photostability protection. In contrast in fast non
radiative processes no profound chemical or structural rearrange
ments can occur [1]. This pathway of ultrafast nonradiative decay
can be observed in many biological systems [1,130,131].
To elucidate additional electronic dynamics from the signals of
the transient absorption DA(t), we need to understand the details
of the electronic transitions in zinc phthalocyanines, which are
induced and probed through the laser pulses in the pump probe
experiments.
To monitor dynamics upon phthalocyanine excitation the time
evolution of transient absorption signals were monitored with a
time resolution of 50 fs.
To obtain insight into the mechanisms of energy dissipation, we
monitored the dynamics of ZnPcS4 at the interfacial region of
human breast tissues upon excitation of the S0! S1 transition in
the Q band at 674 nm (maximum absorption of monomer) and at
633 nm (maximum absorption of dimer) and probing at different
wavelengths (570 nm, 633 nm, 674 nm) corresponding to theexcited state, dimer, and monomer absorption spectra, respective
ly.
Fig. 8 shows the transient absorption signals DA(t) of ZnPcS4 at
the interface of the cancerous tissue, noncancerous tissue, in the
film, and in solution as a function of the time delay in the pump
probe experiments when pumped with 674 nm and probed with
674 nm. The results are presented in the full time window up to
10 ps (Fig. 8a) and in the narrower windows up to 100 ps (Fig. 8b)
and up to 1 ns (Fig. 8c).
The results shown in Fig. 8 indicate that directly upon excitation
at 674 nm, a negative transient absorption DA(t) signal at 674 nm
was recorded. The negative signal was assigned to the bleaching of
the ground state due to the HOMO(a1u) ! LUMO(eg) transition in
the Q band for monomer ZnPcS4 molecules. The bleaching is
instantaneous and limited by the laser pulse width.
The recovery at 674 nm was three exponential and fitted with
time constants of 1.7  0.4 ps, 24.4  3.1 ps and 59.3  4.4 ps for the
noncancerous tissue and 8.3  1.2 ps, 17.8  1.7 ps, and 42.2  1.6 ps
for the cancerous tissue. The recovery in the ZnPcS4 film was also
three exponential, with the time constants 1.8  0.2 ps,
13.1 0.8 ps, and 28.4 1.8 ps. These results indicate that the
dynamics of the ground state recovery are different for the
noncancerous and cancerous tissues, particularly the shortest time
constants (1.7 ps vs 8.3 ps).
The recovery of ZnPcS4 bleaching in solution at 674 nm achieved
the best fit, showing three exponential functions with time
constants of 11.1 0.9 ps, 25.9  0.5 ps, and 307  79 ps. It is
important to stress that the dynamics in the solution contains a
slow component of 307 ps that has not been observed neither in
the tissues nor in the film.
Fig. 9 shows the transient absorption signal DA(t) of ZnPcS4 in
the noncancerous and cancerous human breast tissues, ZnPcS4 film
and aqueous solution as a function of the time delay when pumped
at 633 nm and probed at 633 nm.
Fig. 9 shows that directly upon excitation with the laser pump
pulse at 633 nm, a negative DA(t) signal at 633 nm was recorded.
The negative signal was assigned to the bleaching of the ground
state due to the HOMO(a1u) ! LUMO(eg) transition in the Q band
for ZnPcS4 dimer. The bleaching was instantaneous and limited by
the laser pulse width. The recovery of the bleaching at 633 nm was
three exponential and fitted with time constants of 1.1 0.1 ps,
8.3  0.9 ps, and 51.2  2.6 ps for the noncancerous tissue and
5.6  0.4 ps, 16.1 0.5 ps, and 51.7  3.8 ps for the cancerous tissue.
Fig. 7. a) Absorption spectra of ZnPcS4 in noncancerous tissue (a), cancerous tissue (b), film (c) and aqueous solution c = 10 3M (d); b) Absorption spectra of AlPcS4 in
noncancerous tissue (a), cancerous tissue (b), film (c) and aqueous solution c = 10 3M (d)18.
 9The recovery in the ZnPcS4 film was also three exponential, with
the time constants 1.5  0.1 fs, 9.5  0.6 ps, and 19.8  1.1 ps. These
results indicate that the dynamics of the ground state S0 recovery is
different in the noncancerous and the cancerous tissues. The
recovery of ZnPcS4 bleaching in solution at 633 nm when pumped
at 633 nm was three exponential, with the time constants
12.1 0.7 fs, 72.8  14.1 ps, and 116  27 ps.
Tables 5 and 6 summarize the characteristic time constants for
the dynamics of the ground state by monitoring the DA(t) signal of
bleaching recovery for the monomeric species at 674 nm and the
dimer species at 633 nm.
The results presented in Figs. 8 and 9 clearly demonstrate that
the photochemical properties of photosensitizers in solutions
cannot be directly translated to the biological interfaces. The
comparison of the time constants shown in Tables 5 and 6
demonstrates that the mechanisms of energy dissipation for
phthalocyanines in bulk solutions and at biological interfaces are
dramatically different. First, the dynamics of ZnPcS4 molecules at
the biological interface of noncancerous tissue contains a very fast
component of around 1 ps, which does not exist in bulk solutions.Second, the dynamics of ZnPcS4 in solution contains the slow
component of hundreds of picoseconds, which is not observed at
biological interfaces of the tissues. The time constants in solution
are consistent with those obtained by Howe et al. [60] for PcS4 and
ZnPcS4 in DMSO probed at 720, 790, and 820 nm, but the very fast
component of around 1 ps at biological interfaces is a new feature
suggesting a different channel of energy dissipation.
To gain further insight into the dynamics of ZnPcS4 we
monitored the time evolution of the decay signal in the region
of the excited state absorption (ESA) from S1 to higher Sn states.
Fig.10 shows the ESA transient absorption signal DA(t) of ZnPcS4 in
noncancerous and cancerous human breast tissues, in film and in
aqueous solution (concentration 10 3M) as a function of the time
delay in the full time window up to 10 ps (10a), 100 ps (10b) and
1 ns (10c), pumped at 674 nm and probed at 570 nm.
Fig. 10 shows that the instantaneous bleaching of the negative
signal of ZnPcS4 in the tissues, film, and water solution at 674 nm
presented in Figs. 8 and 9 is accompanied by a sudden rise at
570 nm, followed by decay. This decay is three exponential and
was fitted with time constants of 0.98  0.1 ps, 1.6  0.2 ps,
Fig. 8. Transient absorption signal DA(t) of ZnPcS4 in noncancerous (~), cancerous (&) human breast tissues, film (*) and aqueous solution (concentration 10 3M) (^) as a
function of the time delay in the full time window up to 10 ps (a), 100 ps (b) and 1 ns (c), pumped at 674 nm and .probed at 674 nm.
Fig. 9. Transient absorption signal DA(t) of ZnPcS4 in noncancerous (~), cancerous (&) human breast tissues, film (*) and aqueous solution (concentration 10 3M) (^) as a
function of the time delay in the full time window up to 10 ps (a), 100 ps (b) and 1 ns (c), pumped at 633 nm and probed at 633 nm.
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Table 5
Comparison of time constants for ZnPcS4 at the biological interfaces of noncancerous and cancerous tissues, and in the film and aqueous solution pumped at 674 nm and
probed at 674 nm.
Time constants and amplitudes
Time constant Amplitude Time constant Amplitude Time constant Amplitude Time constant Amplitude
Noncancerous tissue 1.7  0.4 0.04  0.008 24.4  3.1 0.1  0.01 59.3  4.4 0.1  0.006
Cancerous tissue 8.3  1.2 0.04  0.01 17.8  1.7 0.11  0.1 42.2  1.6 0.15  0.1
Film 1.8  0.2 0.005  2.8E-4 13.1  0.8 0.005  6.7E-4 28.4  1.8 0.01  5.6E-4
Aqueous solution 11.1  0.9 0.07  0.005 25.9  0.5 0.27  0.01 307  79 2.92  0.01
Table 6
Comparison of time constants for ZnPcS4 at the biological interfaces of noncancerous and cancerous tissues and in the film and aqueous solution pumped at 633 nm and
probed at 633 nm.
Time constants and amplitudes
Time constant Amplitude Time constant Amplitude Time constant Amplitude Time constant Amplitude
Noncancerous tissue 1.1  0.1 8.3  0.9 51.2  2.6
Cancerous tissue 5.6  0.4 0.8  0.2 16.1  0.5 4.4  0.1 51.7  3.8 7.4  2.4
Film 1.5  0.1 0.06  0.001 9.5  0.6 0.3  0.003 19.8  1.1 0.5  0.01
Aqueous solution 12.1  0.7 1.4  0.1 72.8  14.1 84.1  0.2 116  27 0.05  0.01
Fig. 10. Transient absorption signal DA(t) of ZnPcS4 in noncancerous (~), cancerous (&) human breast tissues, film (*) and aqueous solution (concentration 10 3M) (^) as a
function of the time delay in the full time window up to 10 ps (a), 100 ps (b) and 1 ns (c), pumped at 674 nm and probed at 570 nm.
Table 7
Comparison of the time constants of ZnPcS4 at the biological interfaces of noncancerous and cancerous tissues and in film and solution pumped at 674 nm and probed at
570 nm.
Time constants and amplitudes
Time constant Amplitude Time constant Amplitude Time constant Amplitude Time constant Amplitude
Noncancerous tissue 0.98  0.1 0.04  0.009 1.6  0.2 0.03  0.01 8.9  0.9 0.01  0.003
Cancerous tissue 2.7  0.2 0.005  0.001 11.6  0.5 0.03  0.002 37.0  0.6 0.07  0.001
Film 1.3  0.1 0.01  6.4E-4 11.7  1.5 0.005  0.001 49.2  2.5 0.006  9.1E-5
Aqueous solution 1.3  0.3 0.03  0.14 21.6  1.2 0.09  0.001 108  16 0.001  0.001
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128.9  0.9 ps for the noncancerous tissue and 2.7  0.2 ps,
11.6  0.5 ps, 37.0  0.6 ps for the cancerous tissue. The results in
Fig. 10 clearly demonstrate that the dynamics of ZnPcS4 in the
noncancerous tissue are markedly faster than those in the
cancerous tissue. The decay of the signal in the ZnPcS4 film was
also three exponential, with the time constants 1.3  0.1 ps,
11.7  1.5 ps, and 49.2  2.5 ps. The decay of the signal in the
ZnPcS4 aqueous solution was also three exponential, with the time
constants 1.3  0.3 ps, 21.6  1.2 ps, and 108  16 ps.
Table 7 compares the time constants characterizing the
dynamics of the excited state S1 decay of ZnPcS4 at biological
interfaces of noncancerous and cancerous tissues and in film and
aqueous solution when the monomeric species are excited at
674 nm. The results from Table 7 show that the dynamics of the
excited state S1 decay for the noncancerous tissue is much faster
than that of the cancerous tissue. The dynamics of the noncancer
ous tissue is described with three time constants (0.98  0.1 ps,
1.6  0.2 ps, 8.9  0.9 ps) and does not contain the slow component
observed in the cancerous tissue (37.0  0.6 ps), film (49.2  2.5 ps.)
and solution (21.6  1.2 ps, and 108  16 ps).
It is obvious that the distinct dynamics of ZnPcS4 in the
noncancerous and the cancerous tissues must be associated with
distinct biological environment.
It is worth emphasizing that the dynamics of ZnPcS4 in the
ground and the excited state at biological interfaces reveals three
different time scales: a) relatively fast component ranging around
1 ps, b) a component of a few picoseconds (8 19) and c) relatively
slow component of a few tens of picoseconds (21 72 ps). In
contrast, the dynamics of ZnPcS4 in solutions exhibits a very slow
component in the range of a few hundred picoseconds (108
307 ps) which is not observed at the biological interface of the
tissue. The slow component was previously reported for many
phthalocyanines in solutions (232 ps [15], 2.9 ns [73], 460 [60]).
The longest time constants observed in ZnPcS4 solutions in the
range of 108 307 ps were assigned to the radiative decay via
fluorescence from S1 to the ground state.
The most important question that arises after detailed analysis
of the energy dissipation channels is why dynamics of photosen
sitizer differs so dramatically when studied in solutions and at
biological interfaces. One must be noticed that the interactions
between the photosensitizer and the tissues seem to be evidently
governed by the hydrophobic or hydrophilic properties of the
biological interfaces. Fig. 4a shows that the noncancerous human
breast tissue is dominated by adipose tissue, embedded ducts and
blood vessels. Adipose tissue is hydrophobic as it contains glycerol
derivatives (monooleate derivatives [114]). In contrast, the
cancerous human breast tissue is dominated by epithelial cells
of the ducts, where the cancer occurs (Fig. 4a) The surface of the
this type of tissue is hydrophilic [114] and contains a high amount
of various proteins. Recently we have also proved that water
amount confined in cancerous tissue is markedly higher than that
in noncancerous tissue [114]. These features of the tissues can
explain why the hydrophilic zinc phthalocyanine (ZnPcS4)
interacts with the hydrophilic environment of the cancerous
breast tissue and exhibits dynamics more similar to the dynamics
in aqueous solution than that at the of hydrophobic interface of the
noncancerous breast tissue.
4. Conclusions
The paper focuses on issues that may open up new horizons and
opportunities for understanding the complex spatio temporal
interactions of molecules at biological interfaces in realistically
crowded environment of the human cells and tissues. Despite of
several model studies that have been published so far, no ultrafast
dynamics of human tissue has been reported yet. We have foundspectacular differences in the dynamics of photosensitizers in the
noncancerous and cancerous breast human tissues. So far, the
cancer pathology has been derived from the static properties of
tissues and the dynamic behavior has not been used to
discriminate between the noncancerous and cancerous tissues.
In this paper we examined the ground and the excited state
dynamics of a photosensitizer (ZnPcS4) at the biological interface
of the human breast tissue by the pump probe transient
absorption femtosecond spectroscopy to obtain information
concerning the events occurring in a time scale ranging from
femtoseconds to nanoseconds.
First, the results showed that the dynamics of the photosensi
tizer was markedly faster in the interfacial regions of the biological
tissue than in solutions. Second, the photosensitizer localized in
noncancerous tissue dissipates the energy through different
pathways than that in cancerous breast tissue. We have shown
that the lifetimes characterizing both the ground state S0 and the
first excited state S1 in the interfacial regions of noncancerous
tissue are markedly shorter than those in cancerous tissue.
Summarizing our study proved that femtosecond spectroscopy
open new capabilities in cancer biology and perfectly fit into the
research on functions of biologically active molecules and
understanding of light energy dissipation. Our studies have shown
that for phthalocyanines as for photosynthesis, the reactions of the
photoreceptors rhodopsin, bacteriorhodopsin, photoactive yellow
protein, phytochrome, and flavin chromophores femtosecond
spectroscopy is a unique technique to study ultrafast processes
activated by light collection and molecular mechanisms responsi
ble for harvesting the light energy can be used for practical
applications in cancer diagnostics.
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